×
搜尋
About
About SHINER
History
Research
News
Certificate/License
Events
Product
Drug Products
Medical Devices
Oral Supplements
Cooperate
Consulation Services
In-Licensing/Out-Licensing
Drug Products
Medical Devices
Oral Supplements
Contact
CH /
EN
About shinerpharm
Company Profile
Corporate Vision
Research and Development
Business Cooperation
Latest News
Latest News
Product Introduction
Drug Products
Medical Devices
Oral Supplements
Recruitment
104 Job Bank
Contact Us
Contact Us
News
HOME
News
Certificate / License
Certificate / License
Events
Certificate / License
Shiner Miaoli Zhunan Plant obtains Japan Foreign Manufacturer Accreditation.
14
2023-08
Certificate / License
Shiner Warehouse II obtains Japan Foreign Manufacturer Registration.
12
2023-06
Certificate / License
Secured medical device business permits.
13
2022-01
Certificate / License
Shiner Zhunan Plant obtains the PIC/S GMP certification from TFDA.
28
2019-05
Certificate / License
Shiner's MetaCu Capsules 300mg receives TFDA approval for patients of Wilson's Disease. (NDA, the orphan drug, API: trientine dihydrochloride)
28
2019-05
Certificate / License
Shiner Zhunan Plant underwent an on-site inspection conducted by TFDA.
04
2018-09
Certificate / License
Shiner Zhunan Plant is officially registered, and it's been recognized with a Green Building certification.
10
2018-05
Certificate / License
Shiner's Reosteo 150mg Tablets receives TFDA approval. (NDA, new strengths, API: risedronate sodium)
21
2017-02
Certificate / License
Shiner obtains the necessary building permit to commence construction of a Western pharmaceutical formulation plant in the Hsinchu Science Park.
20
2016-03
Certificate / License
Shiner's pms-Methylphenidate ER 18mg Tablets receives TFDA approval for the treatment of ADHD. (ANDA, API: methylphenidate hydrochloride)
07
2016-03
←
1
2
→